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Abstract  27 
Obesity, particularly in infants, is becoming a significant public health problem that has 28 
reached “epidemic” status worldwide. Obese children have an increased risk of 29 
developing obesity related diseases, such as metabolic syndromes and diabetes, as well 30 
as increased risk of mortality and adverse health outcomes later in life. Experimental 31 
data show that maternal obesity has negative effects on the offspring’s health in the 32 
short and long term. Increasing evidence suggests a key role for microbiota in host 33 
metabolism and energy harvest, providing novel tools for obesity prevention and 34 
management. The maternal environment, including nutrition and microbes, influences 35 
the likelihood of developing childhood diseases, which may persist and be exacerbated 36 
in adulthood. Maternal obesity and weight gain also influence microbiota composition 37 
and activity during pregnancy and lactation. They affect microbial diversity in the gut 38 
and breast milk. Such microbial changes may be transferred to the offspring during 39 
delivery and also during lactation, affecting infant microbial colonisation and immune 40 
system maturation. Thus, an adequate nutritional and microbial environment during the 41 
peri-natal period may provide a window of opportunity to reduce the risk of obesity and 42 
overweight in our infants using targeted strategies aimed at modulating the microbiota 43 
during early life. 44 
 45 
 46 
 47 
 48 
 49 
 50 
 51 
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1 Introduction 52 
1.1 Obesity, over-nutrition and microbes 53 
Obesity and overweight is becoming a significant public health problem that has reached 54 
“epidemic” status worldwide. There are around 475 million obese adults and over 200 55 
million school-age children with overweight [1]. These children are more likely to be 56 
obese later in life and they have an increased risk of developing obesity-related diseases, 57 
such as metabolic syndromes and diabetes, as well as adverse health outcomes later in 58 
life and premature death [2]. 59 
Globally, overweight and obesity are the fifth leading cause of death, resulting in the 60 
deaths of at least 2.8 million adults annually [3]. The origins of obesity are multifactorial 61 
with complex interactions between genetic, behavioural, social and environmental factors 62 
causing an imbalance between energy intake and energy expenditure, and low-grade 63 
inflammation. 64 
The development of obesity and also, metabolic syndrome has been linked to specific 65 
pathways connecting metabolism with the immune system [4–6]. However, a novel 66 
factor identified as playing a role in human obesity and associated metabolic risks is gut 67 
microbiota. Gut microbiota is involved in nutrient absorption, digestion, protection and 68 
metabolic activities, but also recent evidence suggests that there is a link between gut 69 
microbiota and energy homeostasis, including energy harvest and host adiposity [7, 8]. 70 
Studies in animals and humans have demonstrated that human gut microbial 71 
communities differ between obese and lean individuals; more specifically, obese subjects 72 
showed an increased ratio of Firmicutes to Bacteroidetes, as well as lower microbial 73 
diversity, when compared to lean subjects [9, 10]. However, there are conflicting results 74 
regarding these microbial shifts, including the ratio of Firmicutes to Bacteroidetes in 75 
relation to obesity risk [10]. 76 
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In a germ-free mouse model, obesogenic microbiome transplantation significantly 77 
increased body fat percentage and insulin resistance after two weeks. A recent animal 78 
study [10] reported that the microbiota from obese and lean subjects induced analogous 79 
phenotypes, and microbiota associated with lean subjects reduced adiposity in obese 80 
recipients when combined with an appropriate diet. Furthermore, dietary strategies such 81 
as calorie restriction and exercise have been shown to modulate obesogenic microbiota 82 
[11–13]. 83 
 84 
1.2 Perinatal environment and effects on infant health 85 
Epidemiological studies suggest that an adverse preconception, gestational and post-natal 86 
environment affects programming of the infant for later health. Maternal unbalanced 87 
dietary intake, weight status (under- or over-nutrition) and breast milk composition have 88 
an important effect on the developing embryo [14]. 89 
The maternal metabolism is adjusted during pregnancy to afford the foetus an optimal 90 
intrauterine environment and both under- and over-nutrition may increase the risk of non-91 
communicable diseases (NCDs) later in life [15]. Maternal pre-gestational weight 92 
correlates with birth weight, and maternal obesity has been linked to foetal overgrowth 93 
and macrosomia, congenital defects, neural tube defects, stillbirth, neonatal Apgar score, 94 
pre-term delivery, child morbidity, respiratory problems such as asthma and neonatal 95 
mortality [16–19]. The nutritional environment during pregnancy shapes foetal 96 
development, often manifesting in persistent changes in blood pressure, cholesterol 97 
metabolism, insulin response to glucose and other metabolic and endocrine parameters 98 
[20]. 99 
Maternal gestational environment may create long-lasting and/or permanent 100 
modifications in foetal physiology and these can lead to increased risk of developing 101 
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obesity, diabetes and cardiovascular diseases in adulthood [21, 22]. Several studies have 102 
shown an association between birth weight and the increased risk of certain diseases in 103 
adulthood. Low birth weight is also commonly taken to be a reflection of poor 104 
intrauterine nutritional environment with subsequent long-term health effects. 105 
Epidemiological data on specific prenatal circumstances such as undernutrition have 106 
generated convincing evidence of programming taking place in humans [23]. 107 
Increasingly, evidence suggests the impact of maternal under- and over-nutrition in the 108 
early programming of obesity [24, 25]. If this is the case, maternal nutritional status 109 
during pregnancy and lactation plays an important role for programming the health of our 110 
infants. Experimental and animal studies suggest that maternal obesity during pregnancy 111 
and lactation have negative effects on offspring health, increasing the risk of metabolic 112 
disease [26–28]. Furthermore, maternal obesity is a well-known factor contributing to 113 
pre-eclampsia and impaired glucose response, both of which increase the risk of non-114 
insulin-dependent diabetes and metabolic syndrome later in life [29]. It has also been 115 
found that maternal overweight and obesity before pregnancy are associated with 116 
increased neonatal oxidative stress [30]. Maternal obesity and highmaternal pre-117 
pregnancy body mass index (BMI) are linked to higher rates of C-section [18]. In a 118 
recent longitudinal study of 436 mother-child pairs that were followed until the children 119 
reached seven years of age, C-section and maternal pre-natal exposure to antibiotics 120 
during the last trimester of pregnancy were related to a higher risk of childhood obesity 121 
[31]. Other studies of pre-natal exposure to antibiotics also demonstrated a link with 122 
increased risk of obesity related problems in children aged from 7 to 16 years [32]. 123 
However, there is a biological/physiological relationship between maternal overweight 124 
and breastfeeding success. Rasmussen and colleagues [33] reported that overweight and 125 
obese mothers had a diminished prolactin response in the first post-partum week. Taken 126 
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together, these data suggest that maternal obesity promotes an obesogenic environment 127 
during infancy, which results in an increased risk of obesity. 128 
Recent data suggest the role of microbes and gut microbiota in the metabolic and 129 
immunological programming [34]. Microbes are one of the most important 130 
environmental factors that support the signals involved in immune system development 131 
and maturation [35, 36]. The first microbial contact of neonates is the maternal 132 
microbiota during pregnancy, birth and then through lactation. Thus, a healthy nutritional 133 
and microbial environment during the peri-natal period may provide a window of 134 
opportunity to diminish obesity and overweight development (Fig. 1). Obesity caused by 135 
infants inheriting altered microbiota has been described as a vicious circle [34]. In light 136 
of this it is relevant to develop new strategies to modulate the nutritional and microbial 137 
environment during the peri-natal period, which may reduce the risk of obesity and 138 
overweight both early in life and in the long-term. 139 
Therefore, it is essential to identify which early life events 140 
are related to key environmental exposures to develop new dietary strategies to modulate 141 
the microbial and nutritional parameters associated with the risk of being overweight in 142 
childhood. 143 
 144 
2 Microbiota during the peri-natal period and obesity  145 
Recent reviews highlight how the disruption of maternal microbial transfer caused by 146 
maternal obesity, C-section and also peri-natal exposure to antibiotics may result in 147 
abnormal infant microbial colonisation increasing the risk of obesity in the offspring 148 
[37–41]. Thus, obesity and weight gain during pregnancy, delivery, and lactation 149 
influence infant microbial exposure guiding infant gut colonisation. 150 
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Specific gut microbiota changes during pregnancy favouring proinflammatory status 151 
had been reported [42]. Although this inflammatory status has been associated with 152 
metabolic diseases, the changes during pregnancy could be beneficial for pregnant 153 
women and their babies. In the context, all these changes in gut microbiota 154 
andmetabolismmay be beneficial for the foetus by promotion of energy storage to 155 
support the foetus growth [42]. Furthermore, pregnancy also influences the vaginal 156 
microbiome which is modified in terms of structure and composition with a possible 157 
relationship with pregnancy outcomes [43]. Lactobacillus spp. are predominant in the 158 
vaginal microbiome during pregnancy. Differences in the composition and stability of 159 
the microbial community between pregnant and non-pregnant women have been 160 
observed [44]. There is also increasing evidence associating abnormalities in vaginal 161 
microbiota during pregnancy with pre-term deliveries. Thus, studying the vaginal 162 
ecosystem and detection of pathogens is a key instrument in the prevention of pre-term 163 
delivery and peri-natal infections [45, 46]. 164 
Pregnancy also influences the subgingival microbiota [47] and is linked to high risk of 165 
oral inflammatory-related problems, such as periodontal diseases where microbes play 166 
an important role in the pathogenesis [48]. Research shows periodontal disease and 167 
systemic health are closely linked. Obesity is a significant predictor of periodontal 168 
disease mediated through insulin resistance [49]. Obesity is associated with high plasma 169 
levels of proinflammatory cytokines, which promote inflammatory status increasing the 170 
risk of several diseases. 171 
An association between salivary microbiota and obesity in adolescents and in adult 172 
women has been reported [50,51]. Maternal weight, BMI, and weight gain over 173 
gestation have been related to specific gut microbial shifts [52–54]  and major changes 174 
have been reported between the first and third trimester. There is evidence that 175 
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concentrations of Bifidobacterium spp. are lower in obese and overweight mothers and 176 
in mothers with excessive weight gain than in healthy mothers [52]. Another study 177 
reported similar findings: lower Bifidobacterium spp. and Bacteroides spp. but 178 
increased levels of Staphylococcus, and Escherichia coli spp. in overweight women 179 
compared with lean pregnant mothers [53]. It has been reported an increase in 180 
Proteobacteria and Actinobacteria and also, a reduced bacterial richness at the end of 181 
pregnancy [42]. Specific immune andmetabolic changes during pregnancy have been 182 
also reported, including metabolic syndrome characteristics and these affect microbiota 183 
composition and activity. It appears that microbiota type during the third trimester is 184 
related to inflammation and when isolated and transferred to germ-free mice, adiposity 185 
and insulin insensitivity were increased in the mouse model [42]. 186 
This sequence of events creates a repetitive circle in obese pregnant women in which 187 
the metabolic, immunologic and microbial environments associated with obesity 188 
together affect infant health and development and this would increase their risk for 189 
obesity [54]. Maternal nutritional status also influences gut microbiome during 190 
pregnancy and breastfeeding [53]. Features of faecal microbiota in pregnant women 191 
have been associated with alterations in biochemical parameters. 192 
Parameters such as folic acid, ferritin, transferrin and cholesterol have a special 193 
relevance to the nutritional and maternal health status during gestation. Negative iron 194 
balance throughout pregnancy, may lead to maternal iron-deficiency anaemia during the 195 
third trimester. Folate is a methyl donor that is required to methylate DNA, a critical 196 
epigenetic modification to normal genome and cellular function. The cells’ability to 197 
methylate compounds such as proteins, myelin, etc., will be compromised by a 198 
deficiency of folate. In addition, deficiencies of iron and folic acid during pregnancy 199 
can impact foetal development. A positive relationship between Bacteroides spp. and 200 
9 
 
Bifidobacterium spp. and folic acid levels has been reported. Bacteroides levels were 201 
also related to high-density lipoprotein-cholesterol and lower triglycerides. 202 
On the other hand, lower Bifidobacterium spp. and higher Enterobacteriaceae spp. 203 
levels including E. coli, were linked to high ferritin and low transferrin [53]. Some 204 
studies have examined the association of dietary variables and gut microbiota but 205 
further studies are needed to find out the impact of nutrients in our gut microbes and 206 
also, in our health. Although only long-term diet was correlated with enterotype 207 
clustering [55], other studies observed remarkable differences. In a recent study, 208 
Carrothers and colleagues [56] reported that variation in dietary components, nutrient 209 
and energy intake would be related to the relative abundance of specific bacterial 210 
groups. They observed that in terms of abundant bacterial taxa the gut microbiota of 211 
healthy lactating women is similar to that found in other healthy adult individuals, 212 
although other significant differences could also be observed. Increased intake of some 213 
micronutrients such as pantothenic acid, riboflavin, vitamin B6 and B12 resulted in an 214 
increased abundance of Prevotella and a decreased abundance of Bacteroides. Mineral 215 
intakes such as copper, magnesium, manganese and molybdenum were positively 216 
correlated with Firmicutes and negatively correlated with Bacteroidetes. 217 
Furthermore, the consumption of a calorie-rich diet was positively correlated to 218 
Firmicutes concentrations. Wu and colleagues described a positive association of 219 
Bacteroides with fat and protein consumption, whereas a higher carbohydrate intake 220 
was associated with a relative abundance of Prevotella [55]. However, other studies 221 
reported opposite correlations between specific microbes and macronutrient intake [56]. 222 
One study showed an inverse trend between protein intake and the relative abundance of 223 
Bacteroides while Prevotella was not associated with carbohydrate intake [56]. Further 224 
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studies are needed to examine how dietary variables, and which ones, might affect an 225 
individual´s gut microbiome composition [56]. 226 
 227 
3 Beyond nutrition: the impact of obesity in breast milk composition  228 
Human breast milk (HM) is the best option for infant nutrition and it is considered the 229 
most important post-natal link between infants and mothers. Breast milk is a complex 230 
biological fluid that provides energy, nutrients, and other bioactive compounds such as 231 
enzymes, hormones, proteins, polyamines, microbes and oligosaccharides, for the 232 
development of newborn infants. The biodiversity of microbiota in breast milk has been 233 
assessed recently [57–60] and it was found that Staphylococcus spp., Streptococcus spp. 234 
and some lactic acid bacteria were the most common groups. The breast milk microbiome 235 
is influenced by lactation stage and shaped by maternal health status, maternal BMI, and 236 
weight gain during pregnancy, as well as the mode of delivery and gestational age of the 237 
infant [57, 58, 61–63]. Obese mothers have lower diversity and a distinct microbiota 238 
composition in their breast milk compared to normal-weight mothers [58]. 239 
Lower counts of Bifidobacterium and higher counts of Staphylococcus were detected in 240 
the milk samples of obese mothers than in normal-weight mothers [63]. The higher 241 
presence of Bifidobacterium group in healthy infants also suggests a protective role 242 
against developing specific diseases later in life attributed to breastfeeding [64], as does 243 
the higher abundance of bifidobacteria in breastfed infant gut [65]. Kalliomaki and co-244 
workers reported lower levels of Bifidobacterium spp. In infants who were overweight by 245 
the age of seven years old compared with normal-weight children [66]. They 246 
characterised faecal samples from 25 overweight or obese children and compared these 247 
with samples from 24 normal-weight children. They observed that Bifidobacteria counts 248 
in faecal samples during infancy were significantly higher in children remaining at a 249 
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normal weight at age seven years, whereas significantly greater numbers of 250 
Staphylococcus aureus in infancy were detected in children who subsequently became 251 
overweight [66]. Human milk contains a complex of growth promoting substances, led by 252 
human milk oligosaccharides (HMOs) which promote and support specific microbial 253 
establishment [67]. The presence of Bifidobacterium spp. in breast milk is also 254 
encouraged by these human milk oligosaccharides. HMOs have a clearly “bifidogenic 255 
effect” among other potential benefits attributed to them. Thus, promoting higher 256 
presence of Bifidobacterium supp. early in life may provide protection against 257 
overweight and obesity and exclusive breastfeeding encourages a microbiota dominated 258 
by Bifidobacterium spp. that differs from those who follow other infant feeding 259 
strategies. Nevertheless, the potential impact of microbes on infant health has not yet 260 
been clarified, although it is currently a key challenge in research. 261 
Breast milk also provides immunological components, bioactive compounds and 262 
metabolic hormones that would play a role on the infant’s immune system development 263 
and metabolism during the neonatal period; these compounds would be influenced by 264 
perinatal factors. In a previous study, we have reported that maternal obesity, overweight, 265 
and weight gain over pregnancy guide the immunomodulatory and bioactive breast milk 266 
compounds not only in terms of microbes, but also in terms of TGF-2, sCD14, and 267 
cytokines. It has been reported lower TGF-and sCD14 in overweight and obese breast 268 
milk [63]. Although larger studies using more adequate methods of sample collection and 269 
preparation need to be conducted, a positive association between maternal BMI and 270 
breast milk leptin concentration 271 
has been consistently found in 26 studies included in a systematic review [68]. Leptin is a 272 
hormone present in breast milk, but not in infant formula. Leptin seems to give infants 273 
moderate protection from excessive weight gain, perhaps because it has additional 274 
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downstream effects on infant appetite regulatory pathways, thereby preventing 275 
overweight and obesity development. In some animal studies neonate rats supplemented 276 
with leptin during the suckling period were more resistant to increase of body weight in 277 
adulthood [69, 70], and also more resistant to dietary obesity induced by consumption of 278 
an increased calorie diet [69]. In a recent study, Khodabakhshi and colleagues 279 
investigated differences in the concentrations of leptin, ghrelin and adiponectin, 280 
hormones are involved in appetite and energy balance, in breastmilk samples 281 
frommothers with obese and non-obese children [71]. They reported higher ghrelin 282 
concentrations in the breast milk from mothers with normal-weight children than those 283 
detected in mothers with obese children [71]. 284 
Polyamines are also biologically active compounds present in breastmilk. They play a 285 
key role in the immune system development. Recent studies investigating levels of 286 
polyamines in breast milk samples of obese and lean mothers concluded that obesity was 287 
associated with low concentrations of polyamines in breast milk [72]. In a prospective, 288 
case control study, breastmilk from obese mothers had increased levels of fatty acids with 289 
proinflammatory properties such as palmitic, docosatetraenoic, and stearidonic acids and 290 
also increased levels of fatty acids with lower presence of anti-inflammatory properties 291 
such as gondoic, erucic, nervonic acids, compared to the fatty acid composition profile 292 
observed in lean mothers [73]. All of these studies show the influence of obesity and 293 
nutrition on human breast milk composition.  294 
Taking into account that human breastmilk is the best choice for infant feeding during 295 
early development and that there are several factors that can affect its composition, a 296 
continued basic and clinical research in the field of breastfeeding is needed. 297 
 298 
 299 
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4 Relevance of infant microbial colonisation in the risk of obesity  300 
Gut microbiota colonisation process in infants is a key for later health as alterations in 301 
this process have been linked to a high risk of specific diseases, including obesity and 302 
allergic diseases [74]. Infant microbial colonisation has an impact on the immune and 303 
endocrine systems [75]. Early infant excessive weight gain has been linked to obesity at 304 
three years of age [76]. These data is associated to other findings regarding early 305 
microbiota composition traits in infants who become obese by seven years of age [66]. 306 
Infants from obese mothers had temporal accelerated cognition and language 307 
development, but these acceleration stops at 18 months of age. This novel observation 308 
would need further studies to identify the potential mechanisms involved [77]. 309 
Mothers with high BMI are more likely to have infants developing overweight than lean 310 
mothers. The maternal microbiota is the most important microbial origin for the infant 311 
gut. Thus maternal obesity could be considered a predictor of child overweight. Several 312 
studies demonstrate that infants born to obese mothers have a different bacterial 313 
colonisation pattern than those born to lean mothers [54, 78] and differences are 314 
maintained during the first years of life. Familial socioeconomic status has also been 315 
shown to have an impact on infant microbiome where differences in levels of Blautia 316 
spp. Eubacterium spp., Oscillibacter spp., and Faecalibacterium spp. were reported in 317 
the infants of obese mothers compared to lean mothers [78]. A recent review showed 318 
that the presence of higher concentrations of Lactobacillus spp. and lower 319 
concentrations of Bacteroides spp. in the infant gut during the first three months of life 320 
may predict the risk of child obesity and overweight [40]. The same review highlighted 321 
the role of Bifidobacteria and Staphylococci in tendency towards overweight, together 322 
with faecal immunoglobulin A levels, which were acquired from breast milk and 323 
secreted later by the gut epithelia. However, the development of overweight may begin 324 
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during the in utero period due to an obesogenic maternal environment providing an 325 
inflammatory and obesogenic environment to the foetus, which in turn affects the 326 
development of the infant from childhood to adulthood [14, 79]. In addition, it has been 327 
demonstrated that the human microbiome’s development begins prior to birth as 328 
specific microbes and microbial DNA have been detected in the placenta, umbilical 329 
cord, amniotic fluid (prior to delivery), and infant meconium [24, 80, 81]. Thus, shifts 330 
in maternal microbiota depending on the mother’s diet, health status and lifestyle may 331 
be transferred to the infant, while in utero and during birth. Recent studies show that 332 
maternal health, such as allergic problems as atopic disease and also, type-2 diabetes 333 
mellitus (DM) affects meconium microbiota [82, 83]. As already mentioned, obesity in 334 
mother is linked to C-section, and it has been shown that infants born via C-section 335 
have an increased risk of developing asthma, allergies, respiratory problems, type-1 336 
diabetes and obesity [84–87] compared to vaginally born infants. In addition, C-section 337 
is associated with child adiposity and also, is associated with increased BMI in infancy, 338 
childhood and later in life [88]. C-section infants are colonised by different and less 339 
diverse bacterial community spectra [89], even containing microbes present in the skin, 340 
oral cavity and and hospital environment [89–92]. 341 
Peri-natal antibiotic administration is related to C-section deliveries and it strongly 342 
affects the initial establishment of neo-natal microbiota [92, 93]. In a large cohort of 343 
6114 boys and 5948 girls, early post-natal antibiotic exposure has been linked with later 344 
obesity and overweight [94]. This study reported that early antibiotic administration (<6 345 
months of life) was related to an increased infant body mass. In addition, the same 346 
authors reported a distinct body mass increase associated with cephalosporins and 347 
macrolides, especially in boys. Those studies suggest a potential effect of antibiotics on 348 
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metabolic and microbiological programming that increases the risk of obesity and 349 
overweight. 350 
Using an animal model, it has been demonstrated that low doses of antibiotics at birth 351 
are sufficient to modify early microbiota during maturation and also alter host 352 
metabolism, adiposity, and the expression of immune genes [37]. Furthermore, the 353 
phenotype was transferred to germ-free hosts, showing that microbial composition 354 
changes, not antibiotics per se, play a causal role in metabolism and weight gain. 355 
Therefore, a potential link is suggested between microbiota exposure and colonisation 356 
patterns and C-section, antibiotic use, and the risk of obesity. 357 
Several differences have been observed between gut and upper respiratory tract 358 
microbiota of exclusively breast-fed and formula-fed infants [95–100]. Bifidobacterium 359 
group is more frequent in breastfed but other compositions are also common. Among 360 
breastfed infants, the maternal transmission of specific intestinal bacterial strains has 361 
been described [99–101], supporting the maternal microbial transfer hypothesis and 362 
suggesting unique family-specific strains in each mother-infant dyad. Additionally, 363 
human milk contains milk glycans such as oligosaccharides, glycoproteins, and 364 
glycolipids, which have also been recognised as modulators and drivers of infant 365 
microbiota development that promote the growth and activity of specific bacterial 366 
populations, in particular Bifidobacterium and Bacteroides spp. [102, 103]. 367 
 368 
5 Strategies to modulate maternal microbiota 369 
Diet has an important effect on gut microbiota composition. This suggests the 370 
possibility of using dietary intervention strategies to induce modifications that can have 371 
an impact on human physiology. In a recent study [104] with Macaca fuscata (Japanese 372 
macaque), the role of a high-fat maternal diet on the neonatal microbiome, which in turn 373 
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affects the intestinal maintenance of metabolic health in the offspring, has been 374 
demonstrated. Consequently, the contribution of specific gut bacteria, together with 375 
nutrition and lifestyle counselling, may provide health benefits and may also help to 376 
alleviate the disorders associated with an aberrant gut microbiota composition. 377 
Increasing evidence suggests that early dietary interventions with probiotics may result 378 
in programming effects on adult health. 379 
In recent years, several bacterial strains have been evaluated to understand their possible 380 
role in these disorders. Maternal dietary intervention using specific probiotics may be 381 
beneficial for metabolic status and also, affects foetal physiology [105]. Probiotics 382 
during pregnancy would benefit certain clinical conditions. A recent review of 37 pre-383 
natal probiotics studies demonstrated that probiotics modulate immune markers in the 384 
serum and breast milk, improve maternal glucose metabolism, and reduce the incidence 385 
of gestational diabetes and pre-eclampsia [106]. It is also reported that probiotics were 386 
able to reduce the central adiposity during the first six months postpartum [107]. 387 
Probiotics pre-natally and post-natally affected plasma glucose and insulin sensitivity 388 
[108]. In addition, in a randomised, prospective, parallel group, combining dietary 389 
counselling and probiotics resulted in better glucose regulation during and after 390 
pregnancy due to the intervention. Therefore, dietary and probiotic interventions may be 391 
a good tool for preventing and alleviating metabolic disorders in late pregnancies [109], 392 
when many metabolic imbalances occur. Nutrition counselling combined with probiotic 393 
interventions has been shown to have a beneficial impact on gestational diabetes and 394 
also, reduce the foetal overgrowth associated with maternal diabetes [110]. Peri-natal 395 
probiotic intervention ameliorated weight gain in infants who developed overweight 396 
during infancy, and the effect was most pronounced in infants at the age of four years 397 
[111]. The same study reported that intervention reduced the birth-weight-adjusted 398 
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mean BMI at the age of four years. Impaired glucose regulation and other metabolic 399 
disorders in the mother during pregnancy and breastfeeding can affect the offspring’s 400 
health in early and later life [34]. Taking probiotics during gestation and lactation has 401 
been reported to modulate the infant Bifidobacterium spp. colonisation and also to 402 
influence breast milk microbiota composition compared with placebo group [112]. 403 
Recently it has been reported the effects of peri-natal probiotic supplementation on 404 
breast milk composition, including Bifidobacterium spp. and Lactobacillus spp. and also 405 
functional components such as HMOs and lactoferrin [113]. The same study only 406 
benefitted mothers with vaginal deliveries while no differences were noted in milk 407 
samples from women who delivered by C-section suggesting a probiotic-dependent 408 
milk microbiota modulation in mothers with vaginal delivery. 409 
In addition to all these nutritional strategies to modulate the microbiota there are other 410 
interventions such as exercise, faecal transplantation (not during pregnancy) and 411 
bariatric surgery that have demonstrated an impact on the gut microbiome. Exercise 412 
could be able to modulate the gut microbiota composition and may potentially benefit 413 
the host. Recent animal studies showed that exercise increased Bifidobacterium spp. and 414 
Lactobacillus spp. and significantly altered overall microbial composition and also 415 
increased n-butyrate concentrations [114–116]. In a recent review, Mika and colleagues 416 
reported that early-life exercise increases gut bacterial species involved in promoting 417 
physiological and metabolic health [117]. However, no data is available for pregnant 418 
mothers although the great benefits of exercise during pregnancy on maternal health and 419 
peri-natal outcomes are well known [118]. Further studies should cover the impact of 420 
maternal exercise on microbiome and the impact on their offspring’s health. 421 
Another recent approach is faecal transplantation. In recent years, there is an incredible 422 
increase of the use of microbial replacement therapy named “faecal microbiota 423 
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transplantation” which has been shown to be effective in Clostridium  difficile 424 
infections, and other problems as ulcerative colitis and irritable bowel syndrome [119, 425 
120]. This type of intervention remains experimental in cases of recurrent Clostridium 426 
difficile infections, where no alternative effective treatments exist, and never in the case 427 
of pregnancy [121]. However, several aspects such as safety and therapeutic evidence 428 
should be considered and no information about its use during pregnancy and lactation 429 
have been reported. Bariatric surgery has been shown to be an effective tool for long-430 
term weight loss in individuals affected by severe obesity. Bariatric surgery helps to 431 
improve obesity-related conditions such as type-2 diabetes (T2D), high blood pressure, 432 
cholesterol levels and the risk of cardiovascular diseases. Given the role of gut 433 
microbiota in host metabolism, a recent study investigated the long-term effects of two 434 
different types of bariatric surgery on the microbiome of these patients. It showed that 435 
both procedures induced similar and long lasting effects on their gut microbiomes 436 
compared with obese controls [122]. Transfer of gut microbiota from post-surgical to 437 
intact germ-free mice resulted in a decrease in the weight and fat mass of the recipient 438 
animals. These studies suggest that changes in gut microbiota contribute to reduce 439 
weight and adiposity after bariatric surgery [122,123]. In a recent meta-analysis and 440 
systematic review, including 17 non-randomised or case-control studies, has been 441 
reported that bariatric surgery improved some pregnancy outcomes as a significant 442 
lower incidence of preeclampsia, gestational diabetes and large neonates, however high 443 
prevalence of small neonates, preterm birth, admission in NICU among others, have 444 
been reported [124]. Same study showed that laparoscopic adjustable gastric banding 445 
has not effect on small neonates compared to the other gastric surgeries. These 446 
operations are becoming more frequent among women during their reproductive years. 447 
We have discussed the benefits of bariatric surgery, but there is a risk of adverse 448 
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pregnancy outcomes after bariatric surgery and obese women undergoing surgery need 449 
to be aware of these potential outcomes. Malabsorptive gastric surgery is associated 450 
with an increased risk of foetal growth restriction. Although bariatric surgery decreases 451 
the risk of gestational diabetes, it is strongly associated with small for gestational age 452 
[125]. Moreover, adverse pregnancy outcomes including a higher rate of stillbirths are 453 
observed in pregnancies occurring during the first year after bariatric surgery. Then, 454 
pregnancies should be delayed at least one year after bariatric surgery [126]. 455 
Considering all the information provided in the review, there is a window of 456 
opportunity during early infant life in which maternal microbes and nutrition play a key 457 
role in long-term health benefits mothers-infant dyads. 458 
 459 
6 Conclusions 460 
The deviated maternal environment including nutrition, hygiene and microbes is 461 
associated with the development of childhood diseases such as obesity that may persist 462 
to adulthood. Maternal obesity and weight gain influence the microbiota present during 463 
pregnancy and lactation, which in turn affect microbial composition and diversity. 464 
Breast milk from obese mothers shows a distinct microbial composition and lower 465 
bacterial diversity and a reduction in immunomodulatory factors. These shifts are 466 
transferred to their offspring during delivery and also during lactation, providing the 467 
neonate with an obesogenic environment driving infant microbial colonisation and 468 
immune system maturation. Increasing our understanding of the role of maternal 469 
bacteria in infant microbiota would help develop new dietary strategies based on 470 
microbial modulation and aimed at the beneficial early programing of child health. 471 
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Figure Legends 840 
 841 
Figure 1. Early nutritional and microbial environment determines adult health. Immune 842 
and metabolic deviation later in life may be the consequence of inadequate bacterial 843 
exposure in early life. Maternal environment, including microbiota composition and 844 
activity, may be transferred to the infant during pregnancy, at delivery and also during 845 
breastfeeding providing the basis for infant development and creating a fingerprint for 846 
short- and long-term effects on health. 847 
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